{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:56:20Z","timestamp":1763016980187},"reference-count":22,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PED"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>Neuroleptic malignant syndrome (NMS) is a potentially life-threatening entity characterized by hyperthermia, autonomic deregulation, decreased mental status, increased muscle tone, and, frequently, by renal failure due to rhabdomyolysis. Classically, it follows administration of antipsychotic medication.<\/jats:p>\n<jats:p>The authors report on 4 patients (2 children and 2 adults) in whom NMS was diagnosed after a CNS insult. No patient was receiving antipsychotic medication. The patients' hospital and clinic charts, radiographic data, and follow-up telephone conversations were reviewed retrospectively.<\/jats:p>\n<jats:p>All 4 patients met diagnostic criteria for NMS. Three patients presented with shunt failure, and 1 patient had undergone a functional hemispherectomy 2 days earlier. One patient with shunt failure received the diagnosis retrospectively. An endoscopic third ventriculostomy alleviated his shunt failure and he remains free of NMS. The other 2 patients underwent treatment for shunt failure, but NMS remained. These 2 patients and the one who had undergone hemispherectomy underwent a trial of intrathecal baclofen, and the NMS resolved. Subsequently, an intrathecal baclofen infusion device was placed in all 3 patients, and the NMS resolved. The 2 patients in shunt failure had a lumbar intrathecal baclofen infusion device. The patient who had undergone hemispherectomy had an intracranial baclofen catheter.<\/jats:p>\n<jats:p>Neuroleptic malignant syndrome is a rare, life-threatening disorder that can occur without the administration of neuroleptic medications. Alleviation of any CNS insult is the first order of treatment. Some patients with persistent symptoms of NMS may benefit from intrathecal delivery of baclofen.<\/jats:p>","DOI":"10.3171\/2009.4.peds08444","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T12:21:19Z","timestamp":1253622079000},"page":"217-221","source":"Crossref","is-referenced-by-count":9,"title":["Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy"],"prefix":"10.3171","volume":"4","author":[{"given":"Scott D.","family":"Wait","sequence":"first","affiliation":[{"name":"Divisions of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco A.","family":"Ponce","sequence":"additional","affiliation":[{"name":"Divisions of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan D.","family":"Killory","sequence":"additional","affiliation":[{"name":"Divisions of Neurological Surgery and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Wallace","sequence":"additional","affiliation":[{"name":"Pediatric Neurosciences, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold L.","family":"Rekate","sequence":"additional","affiliation":[{"name":"Pediatric Neurosciences, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1-0040217","series-title":"J Neurosurg","first-page":"71","article-title":"Intraventricular baclofen infusion for dystonia. Report of two cases","volume":"105","author":"Albright","year":"2006"},{"key":"b2-0040217","series-title":"J Neurosurg","first-page":"225","article-title":"Long-term intraventricular baclofen infusion in beagles","volume":"107","author":"Albright","year":"2007"},{"key":"b3-0040217","series-title":"Neurol Clin","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ncl.2003.12.006","article-title":"The evaluation and management of patients with neuroleptic malignant syndrome","volume":"22","author":"Bhanushali","year":"2004"},{"key":"b4-0040217","series-title":"Med Clin North Am","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993"},{"key":"b5-0040217","series-title":"J Clin Psychopharmacol","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00004714-199808000-00022","article-title":"Acute infectious encephalitis complicated by neuroleptic malignant syndrome","volume":"18","author":"Caroff","year":"1998"},{"key":"b6-0040217","series-title":"Science","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1126\/science.6254148","article-title":"Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment","volume":"210","author":"Chiodo","year":"1980"},{"key":"b7-0040217","series-title":"Arch Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1053\/apmr.2002.32820","article-title":"Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome","volume":"83","author":"Coffey","year":"2002"},{"key":"b8-0040217","series-title":"Ann Med Psychol (Paris)","first-page":"145","article-title":"A non-phenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses","volume":"118","author":"Delay","year":"1960"},{"key":"b9-0040217","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3171\/jns.2005.102.6.1133","article-title":"Prolonged intrathecal baclofen withdrawal syndrome. Case report and discussion of current therapeutic management","volume":"102","author":"Douglas","year":"2005"},{"key":"b10-0040217","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3171\/JNS-07\/10\/0878","article-title":"Infusion of intrathecal baclofen for acute withdrawal. Technical note","volume":"107","author":"Duhon","year":"2007"},{"key":"b11-0040217","series-title":"Med Clin North Am","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0025-7125(16)30265-6","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant","volume":"77","author":"Heiman-Patterson","year":"1993"},{"key":"b12-0040217","series-title":"Am J Psychiatry","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985"},{"key":"b13-0040217","series-title":"Am J Phys Med Rehabil","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00002060-199905000-00012","article-title":"Continuously infused intrathecal baclofen for spastic\/dystonic hemiplegia: a preliminary report","volume":"78","author":"Meythaler","year":"1999"},{"key":"b14-0040217","series-title":"Crit Care Clin","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0749-0704(05)70368-7","article-title":"Serotonin syndrome. A clinical update","volume":"13","author":"Mills","year":"1997"},{"key":"b15-0040217","series-title":"Singapore Med J","first-page":"311","article-title":"Neuroleptic malignant syndrome in organic brain disease and physical illness","volume":"31","author":"Pilo","year":"1990"},{"key":"b16-0040217","series-title":"J Neurosurg Pediatr","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/PED\/2008\/2\/7\/001","article-title":"The importance of the cortical subarachnoid space in understanding hydrocephalus","volume":"2","author":"Rekate","year":"2008"},{"key":"b17-0040217","series-title":"Br J Psychiatry","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1192\/bjp.159.5.709","article-title":"The treatment of neuroleptic malignant syndrome. Are dantrolene and bromocriptine useful adjuncts to supportive care?","volume":"159","author":"Rosebush","year":"1991"},{"key":"b18-0040217","series-title":"Dev Med Child Neurol","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1017\/S0012162200001055","article-title":"Intrathecal baclofen withdrawal simulating neuroepileptic malignant syndrome in a child with cerebral palsy","volume":"42","author":"Samson-Fang","year":"2000"},{"key":"b19-0040217","series-title":"Convuls Ther","first-page":"267","article-title":"Treatment choice in neuroleptic malignant syndrome","volume":"8","author":"Scheftner","year":"1992"},{"key":"b20-0040217","series-title":"Aust N Z J Psychiatry","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/j.1440-1614.1999.00630.x","article-title":"Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases","volume":"33","author":"Trollor","year":"1999"},{"key":"b21-0040217","series-title":"J Psychopharmacol","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/026988110101500111","article-title":"Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen","volume":"15","author":"Turner","year":"2001"},{"key":"b22-0040217","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/0028-3908(81)90024-1","article-title":"Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock (ECS) in rats","volume":"20","author":"Wielosz","year":"1981"}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/4\/3\/article-p217.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/4\/3\/article-p217.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/4\/3\/article-p217.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T11:34:00Z","timestamp":1681558440000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/4\/3\/article-p217.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":22,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2009.4.peds08444","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}